Schmid Michael C, Schulein Ralf, Dehio Michaela, Denecker Geertrui, Carena Ilaria, Dehio Christoph
Division of Molecular Microbiology, Biozentrum, University of Basel, Klingelbergstrasse 70, 4056 Basel, Switzerland.
Mol Microbiol. 2004 Apr;52(1):81-92. doi: 10.1111/j.1365-2958.2003.03964.x.
Bartonella henselae is an arthropod-borne zoonotic pathogen causing intraerythrocytic bacteraemia in the feline reservoir host and a broad range of clinical manifestations in incidentally infected humans. Remarkably, B. henselae can specifically colonize the human vascular endothelium, resulting in inflammation and the formation of vasoproliferative lesions known as bacillary angiomatosis and bacillary peliosis. Cultured human endothelial cells provide an in vitro system to study this intimate interaction of B. henselae with the vascular endothelium. However, little is known about the bacterial virulence factors required for this pathogenic process. Recently, we identified the type IV secretion system (T4SS) VirB as an essential pathogenicity factor in Bartonella, required to establish intraerythrocytic infection in the mammalian reservoir. Here, we demonstrate that the VirB T4SS also mediates most of the virulence attributes associated with the interaction of B. henselae during the interaction with human endothelial cells. These include: (i) massive rearrangements of the actin cytoskeleton, resulting in the formation of bacterial aggregates and their internalization by the invasome structure; (ii) nuclear factor kappaB-dependent proinflammatory activation, leading to cell adhesion molecule expression and chemokine secretion, and (iii) inhibition of apoptotic cell death, resulting in enhanced endothelial cell survival. Moreover, we show that the VirB system mediates cytostatic and cytotoxic effects at high bacterial titres, which interfere with a potent VirB-independent mitogenic activity. We conclude that the VirB T4SS is a major virulence determinant of B. henselae, required for targeting multiple endothelial cell functions exploited by this vasculotropic pathogen.
汉赛巴尔通体是一种节肢动物传播的人畜共患病原体,可在猫储存宿主中引起红细胞内菌血症,并在偶然感染的人类中引发广泛的临床表现。值得注意的是,汉赛巴尔通体能够特异性地定殖于人类血管内皮细胞,导致炎症反应以及形成称为杆菌性血管瘤和杆菌性紫癜的血管增生性病变。培养的人内皮细胞提供了一个体外系统,用于研究汉赛巴尔通体与血管内皮细胞之间的这种密切相互作用。然而,对于这一致病过程所需的细菌毒力因子知之甚少。最近,我们鉴定出IV型分泌系统(T4SS)VirB是巴尔通体中一种必需的致病因子,是在哺乳动物储存宿主中建立红细胞内感染所必需的。在此,我们证明VirB T4SS在与人类内皮细胞相互作用期间也介导了与汉赛巴尔通体相互作用相关的大多数毒力特性。这些特性包括:(i)肌动蛋白细胞骨架的大量重排,导致细菌聚集体的形成及其被侵袭体结构内化;(ii)核因子κB依赖性促炎激活,导致细胞粘附分子表达和趋化因子分泌,以及(iii)抑制凋亡细胞死亡,导致内皮细胞存活率提高。此外,我们表明VirB系统在高细菌滴度下介导细胞生长抑制和细胞毒性作用,这会干扰一种强大的不依赖VirB的促有丝分裂活性。我们得出结论,VirB T4SS是汉赛巴尔通体的主要毒力决定因素,是靶向这种嗜血管病原体所利用的多种内皮细胞功能所必需的。